Filing Flows › PAR Technology (PAR) › Guidance & outlook
PAR Technology (PAR) guidance and outlook
PAR Technology (PAR) raised its guidance on Nov 5, 2026: Revenue $138M–$142M for the quarter ending Dec 31, 2026; EBITDA $17.5M–$19.0M for the quarter ending Dec 31, 2026; Revenue $532M–$536M for FY2026; EBITDA $57.9M–$59.4M for FY2026. PAR Technology's 10-Q filed Nov 5, 2026 makes 3 forward-looking statements.
Guidance and outlook
Latest guidance
| Metric | Period | Range | Change |
|---|---|---|---|
| Revenue | the quarter ending Dec 31, 2026 | $138M–$142M | new |
| EBITDA | the quarter ending Dec 31, 2026 | $17.5M–$19.0M | new |
| Revenue | FY2026 | $532M–$536M | raised |
| EBITDA | FY2026 | $57.9M–$59.4M | raised |
From the earnings release filed Nov 5, 2026 (8-K on EDGAR).
Forward-looking statements, 10-Q filed Nov 5, 2026
- As a result of these events, we anticipate increased supply chain challenges, commodity cost volatility, and consumer and economic uncertainty.
- We cannot provide assurance that any additional financing or strategic alternatives will be available to us on acceptable terms or at all.
- If our share price and market capitalization decline further for a sustained period, particularly if accompanied by deterioration in our operating results, forecasts, peer valuation multiples, or other market-participant assumptions, we may be required to perform additional impairment testing.
PAR Technology's latest quarter
PAR Technology, Q3 2026: revenue $137M (+15% year over year), operating margin -4.0%, net loss $9.0M, operating cash flow $20.8M. The chart follows the revenue to costs, profit and cash.
Questions
Did PAR Technology raise or lower its guidance?
PAR Technology (PAR) raised its guidance on Nov 5, 2026: Revenue $138M–$142M for the quarter ending Dec 31, 2026; EBITDA $17.5M–$19.0M for the quarter ending Dec 31, 2026; Revenue $532M–$536M for FY2026; EBITDA $57.9M–$59.4M for FY2026.
What does PAR Technology expect?
As a result of these events, we anticipate increased supply chain challenges, commodity cost volatility, and consumer and economic uncertainty. We cannot provide assurance that any additional financing or strategic alternatives will be available to us on acceptable terms or at all. If our share price and market capitalization decline further for a sustained period, particularly if accompanied by deterioration in our operating results, forecasts, peer valuation multiples, or other market-participant assumptions, we may be required to perform additional impairment testing.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.